Einstein Experts for Media

Search Results

You searched for "translational medicine"

3 results found

Paul R. Marantz, M.D., M.P.H.

Paul R. Marantz, M.D., M.P.H.

Associate Dean, Clinical Research Education, Einstein

Associate Director, Block Institute for Clinical and Translational Research at Einstein and Montefiore

Professor, Epidemiology & Population Health, Einstein

Professor, Medicine (General Internal Medicine), Einstein

Research educationClinical research methodsPublic health

Translational medicine

Dr. Marantz is an innovator in developing educational programs in clinical medicine, research methods, and public health for medical students, residents, physicians, and other health professionals.  He is co-director of Einstein’s Clinical and Translational Science Award program, a national, NIH-funded consortium working to improve patient care by reducing the time it takes for laboratory discoveries to make their way into medical practice. read more...

 

Vern L. Schramm, Ph.D.

Vern L. Schramm, Ph.D.

Professor, Biochemistry

Ruth Merns Chair in Biochemistry

BiochemistryEnzymesTranslational medicine

RicinAutoimmune diseases

Dr. Schramm is a member of the National Academy of Sciences and associate editor of the Journal of the American Chemical Society.  His pioneering work in biochemistry has resulted in powerful new strategies for treating cancer, antibiotic resistance and autoimmune diseases. read more...

 

Ulrich G. Steidl, Ph.D., M.D.

Ulrich G. Steidl, Ph.D., M.D.

Professor, Cell Biology

Professor, Medicine

Deputy Director, Albert Einstein Cancer Center

Rose C. Falkenstein Chair in Cancer Research

Interim Director, The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research

Leukemias and myelodysplastic syndromes Pre-cancerous and cancer stem cellsCell and tumor biology

Dr. Steidl studies the molecular and cellular mechanisms that lead to two related blood diseases, myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His NIH-funded basic and translational research seeks to define the characteristics of pre-leukemic stem cells (pre-LSC), understand their progression to leukemic stems cells, and develop drug strategies to target the process. Dr. Steidl is co-director of the Albert Einstein Cancer Center's Blood Cancer Institute. read more...